Publication | Closed Access

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Surgical OncologyGastrointestinal OncologyMedicinePaclitaxel Versus PlaceboGastroenterologySurgeryAdvanced GastricCancer TreatmentOncologyPhase 3